NF-κB signaling is frequently misregulated in cancer including GBM [60] and has been associated with the regulation of stemness, as well as immune evasion processes [61], while aberrant interferon signaling has been associated with increased proliferation and mesenchymal phenotype of GBM cells [62]. Here, NFKB1 is linked to glioblastoma.